EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Fucoidan as a therapeutic agent for ulcerative colitis: mechanisms of action and modulation of the gut microbiota

Yating Zhang

Frontiers in Cellular and Infection Microbiology · 10.07.2025 · 15

DOI: 10.3389/fcimb.2025.1626614 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 10.07.2025. Verfasst von Yating Zhang. Beteiligte Einrichtung: College of Bioscience and Biotechnology, Hunan Agricultural University, Hunan Provincial Engineering Research Center of Applied Microbial Resources D…. Hauptthemen laut MEDLINE: Polysaccharides, Gastrointestinal Microbiome, Colitis, Ulcerative, Anti-Inflammatory Agents. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ulcerative colitis (UC), a chronic inflammatory bowel disease driven by gut dysbiosis, immune dysregulation, and oxidative stress, lacks universally effective therapies. Fucoidan (FCD), a sulfated polysaccharide derived from brown algae, has emerged as a multifaceted therapeutic candidate due to its anti-inflammatory, antioxidant, and immunomodulatory properties. This review synthesizes FCD’s mechanisms in UC pathogenesis, emphasizing its suppression of NF-κB and MAPK signaling pathways to reduce proinflammatory cytokines (e.g., IL-6, TNF-α) and regulate TLR-mediated macrophage polarization. FCD enhances intestinal barrier integrity via upregulation of tight junction proteins (Claudin-1, ZO-1) and mucin MUC2 expression, while remodeling gut microbial ecology through enrichment of SCFAs-producing bacteria (e.g., Ruminococcaceae) and suppression of pathogens (Escherichia coli, Candida albicans). Preclinical studies highlight LMWF as a superior candidate, demonstrating enhanced bioavailability and efficacy in mitigating DSS-induced colitis. Despite its promise, challenges persist in structural heterogeneity (source- and extraction-dependent), scalable production of LMWF, and insufficient pharmacokinetic data. Emerging strategies—including nanoparticle-based delivery systems and structural modifications (cross-linking, covalent bonding)—aim to overcome bioavailability limitations. This review underscores FCD’s potential as a functional food or adjuvant therapy for UC, while advocating for rigorous clinical validation to bridge translational gaps, Enrichment of SCFAs-producing taxa and suppression of pathobionts ( Escherichia coli , Candida albicans ), mediated through prebiotic fermentation. Suppression of NF-κB activation via IκBα stabilization and inhibition of p65 nuclear translocation, and downregulation of MAPK phosphorylation (ERK1/2, JNK, p38), reducing proinflammatory cytokines (IL-6, TNF-α, IL-1β). FCD can be used as a potential treatment for UC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PolysaccharidesGastrointestinal MicrobiomeColitis, UlcerativeAnti-Inflammatory AgentsHumansAnimalsCytokinesNF-kappa BSignal Transduction

Stichwörter der Autor:innen

Fucoidangut microbiotainflammationoxidative stresstoll-like receptors (TLRs)ulcerative colitis

Substanzen

fucoidanPolysaccharidesCytokinesAnti-Inflammatory AgentsNF-kappa B

Autor:innen und Institutionen

  • College of Bioscience and Biotechnology, Hunan Agricultural University, Hunan Provincial Engineering Research Center of Applied Microbial Resources Development for Livestock and Poultry, Changsha, Hunan, China.

Zitieren

APA

Zhang, Y. (2025). Fucoidan as a therapeutic agent for ulcerative colitis: mechanisms of action and modulation of the gut microbiota. Frontiers in Cellular and Infection Microbiology, 15. https://doi.org/10.3389/fcimb.2025.1626614

Vancouver

Zhang Y. Fucoidan as a therapeutic agent for ulcerative colitis: mechanisms of action and modulation of the gut microbiota. Frontiers in Cellular and Infection Microbiology. 2025;15. doi:10.3389/fcimb.2025.1626614

BibTeX
@article{Zhang2025,
  author = {Zhang, Yating},
  title = {Fucoidan as a therapeutic agent for ulcerative colitis: mechanisms of action and modulation of the gut microbiota},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  volume = {15},
  doi = {10.3389/fcimb.2025.1626614}
}
Kostenlos starten →